Nuvation Bio Inc.
NUVB
$6.22
$0.121.97%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.16% | 75.92% | 63.97% | 59.14% | 60.27% |
| Total Depreciation and Amortization | 104.87% | 110.16% | 154.61% | 173.41% | 154.13% |
| Total Amortization of Deferred Charges | 7,205.56% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.62% | -90.39% | -90.93% | -91.32% | -92.56% |
| Change in Net Operating Assets | -2,770.99% | -410.53% | 4.22% | -72.87% | 111.40% |
| Cash from Operations | 28.34% | 20.09% | -32.98% | -91.64% | -99.73% |
| Capital Expenditure | -3.87% | -59.42% | -118.52% | -34.04% | -525.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.73% | -100.73% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.57% | -98.71% | -9.56% | -29.64% | 259.88% |
| Cash from Investing | -124.84% | -98.99% | -18.89% | -38.32% | 190.50% |
| Total Debt Issued | 24.69% | 1,566.29% | 1,566.29% | 2,806.54% | 2,806.54% |
| Total Debt Repaid | -526.12% | 28.11% | 27.80% | 11.85% | -82.55% |
| Issuance of Common Stock | 182.37% | 89.15% | 133.80% | 6.45% | 131.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -176.27% | -- | -- | -- | -- |
| Cash from Financing | -6.47% | 23,446.74% | 61,088.82% | 14,228.05% | 6,357.62% |
| Foreign Exchange rate Adjustments | -300.50% | -197.35% | -158.50% | 262.05% | 410.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.02% | 474.84% | 1,953.35% | 1,120.72% | 1,454.15% |